Compare Mitra Energi Persada Tbk. (KOPI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitra Energi Persada Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Mitra Energi Persada Tbk. trades at Rp199 (market cap 145.03B, 7.79M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Mitra Energi Persada Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| KOPI | SCPI | |
|---|---|---|
Market Cap | 145.03B | 104.4B |
Volume | 7.79M | — |
Lot | 77.94K | — |
Turnover | 1.71B | — |
Average Price | 219.42 | — |
Value | 1.71B | — |
Indicative Equilibrium Price | 199 | — |
Indicative Equilibrium Volume | 693 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mitra Energi Persada Tbk.
PT Mitra Energi Persada Tbk (formerly PT Korpora Persada Investama, Tbk) (the "Company") a public listed company registered in Indonesia Stock Exchange) was first established under the name of Adwitiya Alembana an Advertising Company, drawn up before notary Kartini Muljadi, SH No. 200 dated 24 February 1981. The Company is domiciled in Jakarta and started operations since 1982.
Read more on KOPI →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
